Literature DB >> 20308634

Histone acetylation at the single-cell level: a marker of memory CD8+ T cell differentiation and functionality.

Joanna R Dispirito1, Hao Shen.   

Abstract

Following stimulation, memory T (T(M)) cells rapidly express many effector functions, a hallmark feature that allows them to provide protective immunity. Recent studies suggest that genes involved in this rapid recall response may maintain an open chromatin structure in resting T(M) cells via epigenetic modifications. However, these studies have mostly focused on a few loci, and the techniques used required a large number of cells. We have developed a flow cytometric assay measuring histone modifications in individual murine T cells in combination with lineage-specific markers. In this study, we show that the per-cell level of a marker of open chromatin, diacetylated histone H3 (diAcH3), increases as naive CD8(+) T cells develop into T(M) cells, demonstrating a novel correlation between the differentiation state of a CD8(+) T cell and its abundance of a specific histone modification. Furthermore, our results show that T(M) cells defective in rapid recall ability have less diAcH3 than their fully functional counterparts, indicating that the diAcH3 level of individual T(M) cells is a useful marker for assessing their functionality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308634     DOI: 10.4049/jimmunol.0903830

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells.

Authors:  Ben Youngblood; Carl W Davis; Rafi Ahmed
Journal:  Int Immunol       Date:  2010-08-23       Impact factor: 4.823

Review 2.  Environmental epigenetics and allergic diseases: recent advances.

Authors:  J S Kuriakose; R L Miller
Journal:  Clin Exp Allergy       Date:  2010-08-16       Impact factor: 5.018

Review 3.  The interface between transcriptional and epigenetic control of effector and memory CD8⁺ T-cell differentiation.

Authors:  Simon M Gray; Susan M Kaech; Matthew M Staron
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

4.  Epigenetic manipulation restores functions of defective CD8⁺ T cells from chronic viral infection.

Authors:  Fuqin Zhang; Xiaohui Zhou; Joanna R DiSpirito; Chuan Wang; Ying Wang; Hao Shen
Journal:  Mol Ther       Date:  2014-05-27       Impact factor: 11.454

5.  Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression.

Authors:  Shoko Kuroda; Maya Yamazaki; Manabu Abe; Kenji Sakimura; Hiroshi Takayanagi; Yoshiko Iwai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

6.  Differentiation-dependent functional and epigenetic landscapes for cytokine genes in virus-specific CD8+ T cells.

Authors:  Alice E Denton; Brendan E Russ; Peter C Doherty; Sudha Rao; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

7.  Histone deacetylation critically determines T cell subset radiosensitivity.

Authors:  Jason L Pugh; Alona S Sukhina; Thomas M Seed; Nancy R Manley; Gregory D Sempowski; Marcel R M van den Brink; Megan J Smithey; Janko Nikolich-Žugich
Journal:  J Immunol       Date:  2014-07-02       Impact factor: 5.422

Review 8.  The dynamic lives of T cells: new approaches and themes.

Authors:  Yvonne J Yamanaka; Todd M Gierahn; J Christopher Love
Journal:  Trends Immunol       Date:  2012-11-28       Impact factor: 16.687

9.  Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway.

Authors:  Rong Wang; Aizhang Xu; Xueying Zhang; Jie Wu; Andrew Freywald; Jianqing Xu; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

10.  Global Analysis of O-GlcNAc Glycoproteins in Activated Human T Cells.

Authors:  Peder J Lund; Joshua E Elias; Mark M Davis
Journal:  J Immunol       Date:  2016-09-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.